The WEAR-AF study is a prospective, multicenter clinical trial designed to evaluate the efficacy of wearable technology in the detection, monitoring, and management of atrial fibrillation (AF). This study aims to assess how wearable devices, such as smartwatches equipped with electrocardiogram (ECG) capabilities, can be used to identify AF episodes, guide treatment decisions, and ultimately improve patient outcomes.
Participants will be individuals diagnosed with or at high risk for atrial fibrillation. The study will track the accuracy of AF detection, patient adherence to monitoring, and the impact on clinical outcomes, including stroke prevention, symptom management, and quality of life.
The findings from WEAR-AF are expected to contribute to the growing body of evidence supporting the integration of wearable technology into routine clinical practice for AF management, offering insights into its potential to enhance patient care and reduce healthcare costs.
Adults aged 18 years or older.
Diagnosed with paroxysmal or persistent atrial fibrillation.
Scheduled to undergo catheter ablation for atrial fibrillation.
Able to provide informed consent.
Adverse reaction to Skiin garments (e.g. skin allergy)
Pacemaker and/or (ICD) implantable cardioverter defibrillator users.
Pregnancy